EUVIMEDEUVIMED entdecken
Crossref

Integrated Organoid Screening Approaches Enable Preclinical Assessment of Targeted Protein Degrader Efficacy and Target Engagement

M. Hornsfeld, D. Van Grinten, D. Verstegen, S. Kouters, E. Kingma, T. Veenendaal, M. Madej, A. Hua, J. Wang, L. Krenning, J. Wang, M. Putker und 1 weitere

European Journal of Cancer · 2026-11 · 248 · 117629

DOI: 10.1016/j.ejca.2026.117629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von M. Hornsfeld und 12 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hornsfeld, M., Grinten, D. V., Verstegen, D., Kouters, S., Kingma, E., Veenendaal, T., Madej, M., Hua, A., Wang, J., Krenning, L., Wang, J., Putker, M., & Bourre, L. (2026). Integrated Organoid Screening Approaches Enable Preclinical Assessment of Targeted Protein Degrader Efficacy and Target Engagement. European Journal of Cancer, 248, 117629. https://doi.org/10.1016/j.ejca.2026.117629

Vancouver

Hornsfeld M, Grinten DV, Verstegen D, Kouters S, Kingma E, Veenendaal T, et al. Integrated Organoid Screening Approaches Enable Preclinical Assessment of Targeted Protein Degrader Efficacy and Target Engagement. European Journal of Cancer. 2026;248:117629. doi:10.1016/j.ejca.2026.117629

BibTeX
@article{Hornsfeld2026,
  author = {Hornsfeld, M. and Grinten, D. Van and Verstegen, D. and Kouters, S. and Kingma, E. and Veenendaal, T. and Madej, M. and Hua, A. and Wang, J. and Krenning, L. and Wang, J. and Putker, M. and Bourre, L.},
  title = {Integrated Organoid Screening Approaches Enable Preclinical Assessment of Targeted Protein Degrader Efficacy and Target Engagement},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {248},
  pages = {117629},
  doi = {10.1016/j.ejca.2026.117629}
}
Kostenlos starten →